Start of new business of Ono Digital Health Investment

Japanese drugmaker Ono Pharmaceutical (TYO: 4528) has announced the establishment and start of an investment business of Ono Digital Health Investment, GK (ODhI) as a corporate venture capital (CVC) that invests in venture companies in the field of healthcare, other than the ethical pharmaceutical drug-related field.

With growing interest in the healthcare field, the number of venture companies are increasing to solve health-related social issues, such as disease prevention and improvement of quality of life (QOL), by using digital technology. Through ODhI, this wholly-owned CVC, Ono says it will be able to provide new value in the healthcare field by co-creating with venture companies that utilize digital technology.

ODhI will make investments in venture companies regardless of their business stage or location. Through collaborations and other initiatives between promising venture companies both in Japan and overseas and Ono’s affiliates, we are committed to extending healthy life expectancy and realizing a sustainable society.